Anatara Medicine
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Chelation Therapy
- Lyme Disease Treatment
San Francisco, CA
San Francisco's IV therapy market is compact, premium, and closely tied to a biohacking-forward tech executive client base. Clinics cluster in the Marina, Pacific Heights, SoMa, Union Square, and the Financial District, with Silicon Valley spillover in Palo Alto and Menlo Park. UCSF, California Pacific Medical Center, and Stanford Health Care anchor the clinical ecosystem supplying many medical directors. California is a full-practice state for nurse practitioners under AB 890, so some SF clinics now operate with NPs as autonomous prescribers, though most still run RN administration under physician standing orders. Tech employer wellness programs, long-haul flight recovery for frequent international travelers, and the city's runner and cyclist community (Bay to Breakers, SF Marathon) all drive demand. NAD+ and longevity protocols are especially strong here given the local longevity-tech and venture scene, and SoMa mobile IV services serve hotel and corporate travel volume.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The California medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed. California strictly enforces the corporate practice of medicine doctrine, which prevents non-physicians from owning or controlling medical practices that perform IV therapy.